Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

SOLIGENIX, INC.

UEI: GVD4XBVYD9J5CAGE: 44FA7

SOLIGENIX, INC. is a federal contractor, registered under UEI GVD4XBVYD9J5 and CAGE code 44FA7. It has been awarded $56,546,560 in federal contracts. Primary work spans Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology), Research and Development in Biotechnology, and Unknown NAICS. Top awarding agencies include Department Of Health And Human Services and Department Of Health And Human Services (hhs).

Contact Information

Registration and classification details

Registration

UEI Code

GVD4XBVYD9J5

CAGE Code

44FA7

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

For Profit Organization

NAICS Codes

541714Research and Development in Biotechnology (except Nanobiotechnology)(Primary)
541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

SOLIGENIX, INC. specializes in advanced biotechnological research and development, with a focus on therapeutic protein engineering, vaccine platform technologies, and immunomodulatory product development. The company leverages deep expertise in molecular biology, recombinant protein expression syste...

SOLIGENIX, INC. specializes in advanced biotechnological research and development, with a focus on therapeutic protein engineering, vaccine platform technologies, and immunomodulatory product development. The company leverages deep expertise in molecular biology, recombinant protein expression systems, and preclinical pharmacology to advance novel medical countermeasures for infectious diseases and oncology indications. Their technical capabilities include GMP-compatible manufacturing process development, analytical characterization of biologics, and regulatory pathway strategy for FDA submission. SOLIGENIX differentiates itself through proprietary delivery platforms and targeted immune activation approaches, emphasizing translational science from laboratory innovation to clinical readiness. Award history is not available to determine specific agency relationships or project types, so no definitive patterns of engagement with federal entities can be inferred from the provided data. The company operates primarily within the scientific research and development sector, aligned with NAICS 541714, which encompasses custom biotechnology services and applied life sciences R&D. In practice, this means SOLIGENIX delivers specialized contract research and development services to support government and private-sector initiatives in biodefense, pandemic preparedness, and targeted therapeutics. Their market positioning centers on high-complexity, low-volume biologics development requiring stringent quality control and regulatory compliance. SOLIGENIX, INC. is a small business structured as a 2L entity, headquartered in Princeton, New Jersey. The company holds no federal certifications such as 8(a), HUBZone, or WOSB. Its government market presence is defined by its technical specialization in biopharmaceutical innovation rather than broad-scale service delivery. The firm maintains a focused operational footprint centered on R&D laboratories and process development facilities in its Princeton location.

Key Performance Metrics

Awards Count

16

All time

Active

0

Currently performing

Completed

16

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
Export
Awards by Agency Over Time
Awards by Place of Performance

Compete with SOLIGENIX, INC.

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for SOLIGENIX, INC.

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in SOLIGENIX, INC.'s top NAICS codes and agencies

NAICS: 541611
Federal
University Centers for Excellence in Developmental Disabilities Education, Research and Service Community Impact and Capacity Building Initiative: Technical Assistance to Strengthen Outcomes for People with I/DD and Their Families
Solicitation # UCEDD
The Department of Health and Human Services, through the Administration for Community Living and the Administration on Disabilities, has issued a Request for Information to conduct market research for a contract providing network-wide training, technical assistance, and capacity-building support to University Centers for Excellence in Developmental Disabilities Education, Research and Service. The primary objective is to strengthen outcomes for people with intellectual and developmental disabilities and their families in accordance with the Developmental Disabilities Assistance and Bill of Rights Act of 2000. The contemplated scope includes the development of Community Impact Blueprints to scale promising approaches, the creation of a Strategic TA Plan to establish annual levels of effort, and the implementation of technology solutions such as a Core Functions Dashboard and an AI-assisted chatbot. The government is seeking industry feedback on the feasibility of the draft Performance Work Statement, recommended staffing models, and rough order of magnitude cost estimates. Preliminary classification is under NAICS 541611 for Administrative Management and General Management Consulting Services. The anticipated contract structure consists of a base year and four option years, requiring strict adherence to HHS Information Security Program standards and Section 508 accessibility requirements. Interested respondents must submit their capabilities and recommendations by November 3, 2026.
Department Of Health And Human Services

POSTED

8 days ago

DEADLINE

in 5 days
View Details
NAICS: 541712
DIBBS
PISTON, INNER TUBE, A
Solicitation # SPE7M4-27-T-1466
Solicitation SPE7M4-27-T-1466 is a request for quotations issued by the DLA Weapons Support Fluid Handling Division for the procurement of 12,000 units of Piston, Inner Tube, A, identified by NSN 1710-01-478-1536 and Boeing part number 74A430839-2003. This is a restricted source item requiring engineering source approval by the government design control activity. The contract specifies a delivery timeframe of 154 days after receipt of order, with a need ship date of April 6, 2027, and an original required delivery date of March 6, 2028. Shipping is established as FOB Origin, with the final destination being the DLA Distribution DDSP New Cumberland Facility in Pennsylvania. The contract mandates strict adherence to quality and technical standards, including the DLA Master List of Technical and Quality Requirements, with specific prohibitions against the use of Class I ozone-depleting chemicals. Packaging must comply with ASTM D3951 and RP001, while marking and labeling must follow MIL-STD-129 and RQ017 for bare item marking. Inspection and acceptance will occur at the destination per FAR 52.246-2, utilizing sampling methods such as MIL-STD-1916 or ASQ H1331. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and compliance with DFARS 252.225-7001 regarding the Buy American and Balance of Payments Program.
DLA WEAPONS SUPPORT FLUID HANDLING DIVISION

POSTED

9 days ago

DEADLINE

in 4 days
View Details